These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 26770796)

  • 1. Clinical characteristics of patients with Rutherford category IV, compared with V and VI.
    Tsuchiya T; Iida O; Shiraki T; Soga Y; Hirano K; Suzuki K; Yamaoka T; Miyashita Y; Kitayama M; Kajinami K
    SAGE Open Med; 2015; 3():2050312115597087. PubMed ID: 26770796
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predictors of delayed wound healing after endovascular therapy of isolated infrapopliteal lesions underlying critical limb ischemia in patients with high prevalence of diabetes mellitus and hemodialysis.
    Shiraki T; Iida O; Takahara M; Soga Y; Yamauchi Y; Hirano K; Kawasaki D; Fujihara M; Utsunomiya M; Tazaki J; Yamaoka T; Shintani Y; Suematsu N; Suzuki K; Miyashita Y; Tsuchiya T; Uematsu M
    Eur J Vasc Endovasc Surg; 2015 May; 49(5):565-73. PubMed ID: 25747344
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Complex relationship of body mass index with mortality in patients with critical limb ischemia undergoing endovascular treatment.
    Murata N; Soga Y; Iida O; Yamauchi Y; Hirano K; Kawasaki D; Fujihara M; Tomoi Y
    Eur J Vasc Endovasc Surg; 2015 Mar; 49(3):297-305. PubMed ID: 25524520
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lack of Association Between Limb Hemodynamics and Response to Infrapopliteal Endovascular Therapy in Patients With Critical Limb Ischemia.
    Mustapha JA; Diaz-Sandoval LJ; Adams G; Jaff MR; Beasley R; McGoff T; Finton S; Miller LE; Ansari M; Saab F
    J Invasive Cardiol; 2017 May; 29(5):175-180. PubMed ID: 28441640
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An analysis of IN.PACT DEEP randomized trial on the limitations of the societal guidelines-recommended hemodynamic parameters to diagnose critical limb ischemia.
    Shishehbor MH; Hammad TA; Zeller T; Baumgartner I; Scheinert D; Rocha-Singh KJ
    J Vasc Surg; 2016 May; 63(5):1311-7. PubMed ID: 26860642
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Infrapopliteal balloon angioplasty for chronic critical limb ischemia in diabetic patients with uremia: when is it worth the effort?
    Kuusela J; Manninen HI; Karhapää P
    J Vasc Interv Radiol; 2009 Mar; 20(3):342-6. PubMed ID: 19157896
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of infection severity on clinical outcomes in critical limb ischemia with tissue loss after endovascular treatment.
    Makino K; Hirano K; Kobayashi N; Yamawaki M; Araki M; Sakamoto Y; Shinsuke M; Ito Y
    Heart Vessels; 2019 Jan; 34(1):84-94. PubMed ID: 29967952
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Outcomes of the Japanese multicenter Viabahn trial of endovascular stent grafting for superficial femoral artery lesions.
    Ohki T; Kichikawa K; Yokoi H; Uematsu M; Yamaoka T; Maeda K; Kanaoka Y
    J Vasc Surg; 2017 Jul; 66(1):130-142.e1. PubMed ID: 28400218
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of Perioperative Complications After Endovascular Therapy in Diabetic Patients With Critical Limb Ischemia due to Isolated Infrapopliteal Lesions.
    Okamoto S; Iida O; Takahara M; Yamauchi Y; Hirano K; Soga Y; Suzuki K; Uematsu M
    J Endovasc Ther; 2016 Apr; 23(2):371-7. PubMed ID: 26874179
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of clinical outcome of infrapopliteal angioplasty between Korean diabetic and non-diabetic patients with critical limb ischemia.
    Ryu HM; Kim JS; Ko YG; Hong MK; Jang Y; Choi DH
    Circ J; 2012; 76(2):335-41. PubMed ID: 22112858
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of chronic kidney disease on clinical outcomes in patients with peripheral artery disease undergoing endovascular treatment: Analysis from the K-VIS ELLA registry.
    Kim HO; Kim JM; Woo JS; Choi D; Ko YG; Ahn CM; Lee SW; Lee JH; Choi SH; Yu CW; Min PK; Yoon CH; Chae IH; Lee SR; Koh YS; Kim W;
    Int J Cardiol; 2018 Jul; 262():32-37. PubMed ID: 29602580
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endovascular treatment for infrainguinal vessels in patients with critical limb ischemia: OLIVE registry, a prospective, multicenter study in Japan with 12-month follow-up.
    Iida O; Nakamura M; Yamauchi Y; Kawasaki D; Yokoi Y; Yokoi H; Soga Y; Zen K; Hirano K; Suematsu N; Inoue N; Suzuki K; Shintani Y; Miyashita Y; Urasawa K; Kitano I; Yamaoka T; Murakami T; Uesugi M; Tsuchiya T; Shinke T; Oba Y; Ohura N; Hamasaki T; Nanto S;
    Circ Cardiovasc Interv; 2013 Feb; 6(1):68-76. PubMed ID: 23362307
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drug-Coated Balloon Angioplasty of Infrapopliteal Lesions in Patients with Critical Limb Ischaemia: 1-Year Results of the APOLLO Trial.
    Teichgräber U; Lehmann T; Thieme M; Wahl KU; Stelzner C; Bormann A; Götz L; Kroeßner T; Boden H; Maiwald L; Aschenbach R
    Cardiovasc Intervent Radiol; 2019 Oct; 42(10):1380-1390. PubMed ID: 31286197
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Early-phase wound healing and long-term outcomes of a selective endovascular-first approach for treating Rutherford 5 critical limb ischemia with infrainguinal lesions.
    Inoue K; Onohara T; Mikasa K; Furuyama T
    Surg Today; 2016 Nov; 46(11):1301-9. PubMed ID: 27091136
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of renal insufficiency on clinical outcomes in patients with critical limb ischemia undergoing endovascular revascularization.
    Willenberg T; Baumann F; Eisenberger U; Baumgartner I; Do DD; Diehm N
    J Vasc Surg; 2011 Jun; 53(6):1589-97. PubMed ID: 21531529
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and safety of adjunctive drug-coated balloon therapy in endovascular treatment of common femoral artery disease.
    Imran HM; Hyder ON; Soukas PA
    Cardiovasc Revasc Med; 2019 Mar; 20(3):210-214. PubMed ID: 29970328
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immediate and late outcomes of endovascular therapy for lower extremity arteries in Buerger disease.
    Kim DH; Ko YG; Ahn CM; Shin DH; Kim JS; Kim BK; Choi D; Hong MK; Jang Y
    J Vasc Surg; 2018 Jun; 67(6):1769-1777. PubMed ID: 29157680
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Outcomes of tibial endovascular intervention in patients with poor pedal runoff.
    Baer-Bositis HE; Hicks TD; Haidar GM; Sideman MJ; Pounds LL; Davies MG
    J Vasc Surg; 2018 Jun; 67(6):1788-1796.e2. PubMed ID: 29248245
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Real-World Performance of Paclitaxel Drug-Eluting Bare Metal Stenting (Zilver PTX) for the Treatment of Femoropopliteal Occlusive Disease.
    Tran K; Ullery BW; Kret MR; Lee JT
    Ann Vasc Surg; 2017 Jan; 38():90-98. PubMed ID: 27554688
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Worse limb prognosis for indirect versus direct endovascular revascularization only in patients with critical limb ischemia complicated with wound infection and diabetes mellitus.
    Iida O; Takahara M; Soga Y; Yamauchi Y; Hirano K; Tazaki J; Yamaoka T; Suematsu N; Suzuki K; Shintani Y; Miyashita Y; Uematsu M
    Eur J Vasc Endovasc Surg; 2013 Nov; 46(5):575-82. PubMed ID: 24034905
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.